07.10.2010 12:30:00
|
Takeda Pharmaceuticals Awards Accenture a Multi-Year Application and Infrastructure Outsourcing Contract
Takeda Pharmaceuticals North America, Inc. (Takeda) has engaged Accenture (NYSE: ACN) to provide a range of information technology (IT) services under a strategic outsourcing contract. Financial terms of the multi-year contract were not disclosed.
Under terms of the agreement, Accenture will provide Takeda with application and infrastructure outsourcing services. Application outsourcing services include development, testing, and maintenance of all applications supporting Takeda’s operations. Infrastructure outsourcing services include service desk management, data center management, server and storage management, end-user computing, and network management.
The services being provided will enable Takeda to focus on driving new innovation into the marketplace to further enhance its competitive positioning.
"Increasing global demands and expanding geographically require a different business model, and working with Accenture will enable us to have worldwide reach,” said Lee Voight, Vice President, Information Technology, Takeda Pharmaceuticals North America, Inc. "Through this new IT model, Takeda will meet its global technology needs, allowing us to continue the important work of helping patients.”
"Bundling application and infrastructure services will help Takeda to achieve even greater IT standardization and synergies and to reduce operating costs,” said Nathan Hansen, executive partner in Accenture’s Life Sciences practice. "We look forward to delivering outsourcing services to Takeda to enable continued high customer service levels.”
The agreement is designed to improve the efficiency and effectiveness of the IT functions at Takeda by transforming processes and increasing automation using Accenture Global Delivery Network centers in New Delhi and Bangalore, and other Accenture and Takeda facilities in the United States. The contract was signed in late September and begins immediately. The contract covers ex-Japan IT services currently provided by Takeda Pharmaceuticals North America.
About Accenture
Accenture is a global management consulting, technology services and outsourcing company, with approximately 204,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$21.6 billion for the fiscal year ended Aug. 31, 2010. Its home page is www.accenture.com.
About Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.
Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Kohl's Corp.mehr Nachrichten
11.11.24 |
Erste Schätzungen: Kohls legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
27.08.24 |
Ausblick: Kohls präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
13.08.24 |
Erste Schätzungen: Kohls präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
29.05.24 |
Ausblick: Kohls gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Kohl's Corp.mehr Analysen
Aktien in diesem Artikel
Kohl's Corp. | 16,33 | 6,03% |
Indizes in diesem Artikel
S&P 500 | 5 969,34 | 0,35% |